Literature DB >> 59905

125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection.

H Wiegand, G Erdmann, H H Wellhöner.   

Abstract

1. On unilateral injection of sublethal doses of 125I-botulinum A neurotoxin (BTA) into one gastrocnemius muscle of the cat we found after 48 h: a) A disto-proximal gradient of radioactivity (RA) had developed in the sciatic nerve of the injected side. b) The ventral roots of the spinal cord half segments supplying the injected muscle showed a higher RA than the ventral roots of the contralateral control side. c) The spinal cord half segments innervating the injected muscle had a RA much higher than the corresponding segments of the contralateral side. However, a small rise of RA was also observed in the contralateral half segments. 2. In histoautoradiographs of the (ligatured) ventral roots the RA was strictly confined to the intraaxonal space of a few nerve fibres. 3. On injection of equal doses of 125I-BTA into either gastrocnemius muscle we found after 38 h: a) Direct stimulation of only one of the injected muscle caused the RA to reach a higher level in the spinal cord half segments ipsilateral to the stimulated muscle than in the spinal cord half segments of the non-stimulated side. b) Unilateral stimulation of one gastrocnemius nerve under the influence of gallamine or unilateral antidromic stimulation of the dorsal roots L7, S1 failed to cause a difference in RA between stimulated and non-stimulated side.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59905     DOI: 10.1007/bf00498587

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  The neurotoxins of Clostridium botulinum and Clostridium tetani.

Authors:  G P WRIGHT
Journal:  Pharmacol Rev       Date:  1955-12       Impact factor: 25.468

2.  Local tetanus in cats: the influence of neuromuscular activity on spinal distribution of 125 I labelled tetanus toxin.

Authors:  H H Wellhöner; U C Seib; B Hensel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord.

Authors:  E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Proceedings: Type A botulinum toxin in cats: neural ascent and action on spinal cord reflexes.

Authors:  H Wiegand; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  On the similarity of tetanus and botulinum toxins.

Authors:  J Mellanby; P A Thompson; N Hampden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Tetanus toxin: direct evidence for retrograde intraaxonal transport.

Authors:  D L Price; J Griffin; A Young; K Peck; A Stocks
Journal:  Science       Date:  1975-05-30       Impact factor: 47.728

7.  Direct evidence for the specific fixation of Cl. botulinum A neurotoxin to brain matter.

Authors:  E Habermann; I Heller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus.

Authors:  G Erdmann; H Wiegand; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons.

Authors:  K Stöckel; M Schwab; H Thoenen
Journal:  Brain Res       Date:  1975-11-28       Impact factor: 3.252

10.  Local tetanus in cats: neuropharmacokinetics of 125 I-tetanus toxin.

Authors:  H H Wellhöner; B Hensel; U C Seib
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

  10 in total
  58 in total

1.  Mechanism of Botulinum Toxin in the Relief of Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 2.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

3.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 4.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 5.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 6.  Treatment of chronic low back pain with botulinum neurotoxins.

Authors:  Bahman Jabbari
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 7.  Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action.

Authors:  Aparna Wagle Shukla; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 8.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 9.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

10.  Focal arm weakness following intradetrusor botulinum toxin administration in spinal cord injury: Report of two cases.

Authors:  Christopher Goodrich; Henry York; Andrew Shapiro; Peter Howard Gorman
Journal:  J Spinal Cord Med       Date:  2019-01-31       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.